A substantial subgroup of individuals with ADHD displays marked circadian rhythm dysfunction characterized by evening chronotype and delayed biological timing. Insomnia and sleep problems affect up to ~80% of adults and ~82% of children with ADHD, and delayed sleep-wake timing occurs in roughly 73-78% of cases. Objective markers show dim-light melatonin onset (DLMO) delayed by about 45 minutes in children and ~90 minutes in adults, alongside blunted or delayed cortisol rhythms, reduced pineal gland volume, and attenuated peripheral clock-gene expression (e.g., BMAL1/PER2). These physiological findings align with actigraphy and sleep-lab data and persist after controlling for comorbid anxiety or depression, supporting a distinct circadian-phenotype within ADHD.
Intervention studies demonstrate that circadian phase can be advanced and that phase shifts correlate with symptomatic improvement. Low-dose melatonin and morning bright light exposure reliably advance DLMO in children and adults with ADHD; structured sleep programs improve symptoms and functioning in children; and exercise or multimodal chronotherapy approaches effective in non-ADHD evening types merit study in ADHD. A pragmatic clinical pathway is proposed: routine screening for sleep/circadian disturbance, phenotyping via chronotype assessment and sleep tracking (with DLMO when available), and first-line behavioral measures (fixed wake times, morning bright light, evening light restriction/screen hygiene, regularized zeitgebers), with selective low-dose melatonin for confirmed DLMO delay. Rigorous stratified trials are needed to define responders and optimize protocols.
Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.